Turnaround

165 tickers in this investment thesis
Ranks this page's recent reports by score.
Sensata Technologies Holding plc
ST·Technology
A ★★★★Buy
Current$41.30
Target$48.72
Return+18.0%
Oct 30, 2026

Sensata offers attractive cash-flow valuation and improving industrial earnings supported by embedded sensor franchises and deleveraging, although automotive cyclicality and canceled EV programs threaten recurring growth.

Score
81
PayPal Holdings, Inc.
PYPL·Financials
A ★★★★Buy
Current$56.95
Target$67.20
Return+18.0%
Oct 30, 2026

PayPal offers substantial free cash flow, aggressive buybacks, and an attractive earnings valuation, but its recovery depends on restoring branded checkout competitiveness and sustainable transaction-margin growth.

Score
82
Banco Santander (Brasil) S.A.
BSBR·Financials
B ★★★Hold
Current$4.57
Target$5.25
Return+14.9%
Oct 30, 2026

Santander Brasil offers a discounted Brazilian banking franchise with potential upside from credit normalization and earnings recovery, but persistent loan losses and exchange-offer uncertainty constrain the investment case.

Score
70
Centene Corporation
CNC·Healthcare
B ★★★Hold
Current$68.62
Target$72.00
Return+4.9%
Oct 30, 2026

Centene offers a potential earnings recovery supported by Medicaid scale, improved underwriting and debt reduction, but persistent medical-cost inflation and Marketplace enrollment losses threaten the durability of its turnaround.

Score
67
Stanley Black & Decker, Inc.
SWK·Industrials
B ★★★Hold
Current$103.61
Target$107.10
Return+3.4%
Oct 30, 2026

Stanley Black & Decker offers improving margins, cash generation, and financial flexibility through restructuring, but cyclical tool demand and temporary tariff benefits threaten the durability of its earnings recovery.

Score
65
CoStar Group, Inc.
CSGP·Real Estate
B ★★★Hold
Current$28.14
Target$31.86
Return+13.2%
Oct 30, 2026

CoStar's proprietary real estate data franchise and improving residential marketplace profitability support long-term earnings growth, but sharply weaker subscription bookings and acquisition-related capital demands threaten the recovery.

Score
68
Koninklijke Philips N.V.
PHG·Healthcare
B ★★★Hold
Current$27.12
Target$29.60
Return+9.1%
Oct 30, 2026

Philips offers an improving medical technology turnaround supported by stronger margins, cash generation, and modest valuation multiples, although Respironics liabilities and uncertain recurring profitability constrain the upside.

Score
72
UnitedHealth Group Incorporated
UNH·Healthcare
A ★★★★Buy
Current$410.91
Target$444.41
Return+8.2%
Oct 30, 2026

UnitedHealth combines a dominant insurance franchise and recovering healthcare-services earnings with a historically discounted cash-flow valuation, although medical-cost inflation and regulatory scrutiny threaten the durability of its recovery.

Score
75
Whirlpool Corporation
Current$27.31
Oct 29, 2026

Whirlpool could benefit substantially from a housing-driven appliance recovery and successful restructuring, but weak earnings, heavy leverage, dilution, and uncertain cash generation make its equity highly vulnerable to further setbacks.

Score
25
Alexandria Real Estate Equities, Inc.
ARE·Real Estate
C ★★Sell
Current$39.91
Oct 29, 2026

Alexandria Real Estate Equities offers a potentially deep valuation discount backed by specialized life science properties and substantial liquidity, but persistent vacancy, declining FFO, and asset impairments threaten its recovery.

Score
62
Banc of California, Inc.
BANC·Financials
A ★★★★Buy
Current$18.48
Target$21.30
Return+15.3%
Oct 29, 2026

Banc of California offers earnings recovery and tangible equity growth potential following its balance-sheet repositioning, but commercial real estate credit risk and deposit competition could undermine sustained profitability.

Score
75
Ermenegildo Zegna N.V.
ZGN·Consumer Discretionary
B ★★★Hold
Current$13.48
Target$14.30
Return+6.1%
Oct 26, 2026

Ermenegildo Zegna's luxury heritage and accelerating direct-to-consumer growth support a gradual earnings recovery, but weak non-flagship brands, modest capital returns and retail fixed costs constrain upside.

Score
69